HRA006701
Title:
CRISPR-Cas9 Knockout Screen Identifies factors involved in the cytotoxicity of Decitabine
Release date:
2025-01-10
Description:
Decitabine (DAC), a first-line drug for acute myeloid leukemia (AML), has been long-recognized for its DNA demethylation effects. However, its full spectrum of anti-tumor mechanisms remains incompletely understood. Here, we employ a temporally resolved genome-wide CRISPR-Cas9 screen to identify key factors governing DAC response. We also use lncRNA-seq and ChIP-seq techiques to investigate the changes of trancriptome and chromatin occupancy of proteins of interest.
Data Accessibility:   
Open access
BioProject:
Study type:
Cell line related study
Dataset Download
MetaData:
Files:
Aspera Command Line:  Help   

 Note: HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client) or Asepra Command Line.

Individuals & samples
Files
Submitter:   Zhang Zhuqiang / zhangzhuqiang@ibp.ac.cn
Organization:   Institute of Biophysics, Chinese Academy of Sciences
Submission date:   2024-02-18